Article
Future treatments for hepatitis delta virus infection
1 Feb 2020
Abstract excerpt
Around 15-20 million people develop chronic hepatitis delta virus worldwide. Hepatitis delta virus (HDV) is a defective RNA virus requiring the presence of the hepatitis B virus surface antigen (HBsAg) to complete its life cycle. HDV infects hepatocytes using the hepatitis B virus (HBV) receptor, the sodium taurocholate cotransporting polypeptide (NTCP). The HDV genome is a circular single-stranded RNA which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
